AKT1 and metabolic dysfunction-associated steatotic liver disease: The inhibition of the PI3K/Akt/mTOR signaling pathway can trigger autophagy, thereby reducing intracellular lipid accumulation and inflammation levels, and alleviating NAFLD [26].